Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus.
Saved in:
| Title: | Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus. |
|---|---|
| Authors: | Zorn-Pauly L; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin., von Stuckrad ASL; Pediatric Pneumology, Immunology and Intensive Care Medicine, Charité University Medicine Berlin., Klotsche J; German Rheumatism Research Center Berlin, Leibniz Institute (DRFZ)., Rose T; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin., Kallinich T; Pediatric Pneumology, Immunology and Intensive Care Medicine, Charité University Medicine Berlin.; German Rheumatism Research Center Berlin, Leibniz Institute (DRFZ)., Enghard P; Department of Nephrology and Intensive Care Medicine, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health., Ostendorf L; German Rheumatism Research Center Berlin, Leibniz Institute (DRFZ).; Department of Nephrology and Intensive Care Medicine, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health., Burns M; German Rheumatism Research Center Berlin, Leibniz Institute (DRFZ)., Doerner T; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin., Meisel C; Institute for Medical Immunology, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany., Schneider U; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin., Unterwalder N; Institute for Medical Immunology, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany., Burmester G; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin., Hiepe F; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin., Alexander T; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin.; German Rheumatism Research Center Berlin, Leibniz Institute (DRFZ)., Biesen R; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin. |
| Source: | Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2022 Aug 03; Vol. 61 (8), pp. 3396-3400. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
